You can buy or sell Brainsway and other stocks, options, ETFs, and crypto commission-free!
Brainsway Ltd. American Depositary Shares, also called Brainsway, is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). Read More The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel. The listed name for BWAY is Brainsway Ltd. American Depositary Shares.
52 Week High
52 Week Low
— per share
Expected Nov 23, Pre-Market